AZN: Summary for Astrazeneca PLC Common Stock - Yahoo Finance

UK Markets close in 2 hrs 38 mins

AstraZeneca PLC (AZN)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
27.91-0.59 (-2.07%)
At close: 4:02PM EST

27.27 -0.64 (-2.29%)
Pre-market: 8:46AM EST

People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous close28.50
Bid0.00 x
Ask0.00 x
Day's range27.81 - 28.31
52-week range25.55 - 35.04
Avg. volume7,633,472
Market cap71.81B
PE ratio (TTM)31.90
Earnings dateN/A
Dividend & yield0.90 (3.16%)
Ex-dividend dateN/A
1y target estN/A
Trade prices are not sourced from all markets
  • Accesswire37 minutes ago

    Blog Coverage AbbVie Received FDA Approval for Treatment for Marginal Zone Lymphoma

    Upcoming AWS Coverage on AstraZeneca LONDON, UK / ACCESSWIRE / January 20, 2017 / Active Wall St. blog coverage looks at the headline from AbbVie Inc. (NYSE: ABBV ) as the Company announced on January ...

  • Financial Times20 hours ago

    [$$] GSK appoints AstraZeneca executive as global head of pharma

    GlaxoSmithKline has poached its new global head of pharmaceuticals from rival AstraZeneca, marking a change of guard at Britain's biggest drugmaker as it prepares for the arrival of its new chief executive. ...

  • Reuters - UK Focusyesterday

    GSK grabs Astra executive to replace pharma head

    LONDON/DAVOS, Switzerland, Jan 19 (Reuters) - G laxoSmithKline's global head of pharmaceuticals, Abbas Hussain, is to leave Britain's biggest drugmaker after being passed over for the top job and will be replaced by Luke Miels from AstraZeneca. Hussain, the brother of former England cricket captain Nasser Hussain, had been a contender to take over from Chief (Taiwan OTC: 3345.TWO - news) Executive Andrew Witty, who steps down at the end of March, but the job went to GSK's consumer health boss Emma Walmsley.